Are Peptides Safe? What a Nutritionist Wants You to Know Before You Inject.
Scroll Social Media for long enough and you'll find someone talking about a peptide before bed, chasing tissue repair, fat loss, or "anti-ageing" — all without a prescription, a clinician, or a clue what's actually in the vial. As a nutritionist, this biohacking trend worries me for reasons that go beyond the obvious safety red flags. It's not just what people are injecting. It's what happens to their eating, their metabolism, and their long-term health once they start — and stop.
What's Actually Being Sold
Peptides are short chains of amino acids — the building blocks of protein — that can mimic or amplify processes already happening in your body, like tissue repair, metabolism and growth (Rudge, 2026). Compounds like BPC-157, copper peptides (GHK-Cu), melanotan, and unapproved GLP-1/GLP-2 agonists are being marketed like supplements you'd grab off a shelf at Chemist Warehouse! They're not. Many are injectable, unapproved by Australia's TGA, and sourced through import channels with zero quality control (TGA, 2026a). BPC-157, for example, is actually a Schedule 4 prescription-only substance — yet it's promoted online for everything from gut healing to "biohacking" longevity (Piatkowski et al., 2026).
Why I Start With a Baseline, Not a Dose
If a client came to me wanting to explore any of this, the first thing I'd say is: we don't start with the substance, I start with the person. Before anything is introduced to the body — peptide, medication, or otherwise — I want a baseline. Full metabolic and pathology screening, an honest look at current eating patterns, and a clear picture of risk before we monitor anything. That's not gatekeeping; it's basic risk mitigation. Twelve weeks of structured monitoring with a clinician isn't a "nice to have" — it's the difference between catching a problem early and finding out the hard way, in an emergency department, that something was wrong with dosage, purity, or how a compound interacted with what was already going on in someone's body. Unregulated peptide use skips this step entirely. No baseline, no monitoring, no clinician in the loop — just a product and a promise.
The GLP-1 Reality Check
Here's where I want to push back on the hype, including around regulated GLP-1 medications, because the real-world data tells a different story to the clinical trial headlines. Real-world evidence on approved GLP-1 receptor agonists shows meaningfully higher rates of treatment discontinuation and adverse effects than the trials suggest, and the weight loss people actually achieve in everyday practice tends to fall well short of what's reported under tightly controlled RCT conditions (Thomsen et al., 2025). And the part that doesn't get nearly enough airtime: for a large proportion of people, once they come off these medications, the weight comes back. If that's the reality even with medical supervision, proper dosing, and a real prescription — what exactly are we expecting from a version bought online with none of those safeguards?
Are We Building a Generation That's Simply Not Eating Enough?
This is the question that frustrates me as female and as a mum of two young girls. GLP-1 medications — and the peptides mimicking them — work partly by suppressing appetite. That's the point. But appetite suppression isn't the same as good nutrition. I'm increasingly concerned we're not just looking at a "new obesity treatment" landscape — we're looking at a population quietly under-eating: not getting enough protein to preserve muscle, not getting enough micronutrients, and not getting anywhere near the clinical support needed to catch it. Cost is a huge driver here too. Part of why people turn to unregulated peptide alternatives in the first place is that legitimate medical pathways are expensive and gatekept by eligibility criteria (Monjur et al., 2026). So people take the cheaper, unsupervised route — and lose the nutritional safety net along with it.
Where I Land On This and MY honest professional opinion:
I'm not anti-peptide, and I'm not anti-GLP-1. I'm anti-unsupervised. If you're going to explore this space, do it with baseline testing, a clinician, and real monitoring with a nutritionist — not a product from an influencer's affiliate link. And if appetite suppression is part of your journey, food quality and protein intake need to be part of the conversation from day one, not an afterthought once something's already gone wrong. The trend isn't going away. But your long-term health shouldn't be the price of convenience, cost-cutting, or chasing what's trending this week.
About the author: ANNA Barry (MHumNutr) ANutr, NSA.
Sources referenced: Monjur et al. (2026), InSight+/MJA; Piatkowski et al. (2026), The Conversation; Rudge (2026), The Conversation; TGA (2026a); Thomsen et al. (2025), Diabetes, Obesity and Metabolism.